Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2001 May;39(5):1746–1750. doi: 10.1128/JCM.39.5.1746-1750.2001

iceA Genotypes of Helicobacter pylori Strains Isolated from Brazilian Children and Adults

Abdussalam Ali Ramadan Ashour 1, Guilherme Birchal Collares 1, Edilberto Nogueira Mendes 1,*, Valquíria Ribeiro de Gusmão 1, Dulciene Maria de Magalhães Queiroz 2, Paula Prazeres Magalhães 2, Anfrisina Sales Teles de Carvalho 3, Celso Affonso de Oliveira 2, Ana Margarida Miguel Ferreira Nogueira 4, Gifone Aguiar Rocha 2, Andreia Maria Camargos Rocha 2
PMCID: PMC88019  PMID: 11325984

Abstract

Data concerning the geographic distribution of iceA alleles are scarce, and information on the association of the gene with the disease is rare and still controversial. Furthermore, no such study has been developed in Brazil, where duodenal ulcer and gastric adenocarcinoma are very common. We investigated, by PCR, the frequency of iceA alleles and cagA status in Helicobacter pylori strains isolated from 142 patients (62 children and 80 adults; 66 female; mean age, 30.0 years; age range, 3 to 78 years) with gastritis, duodenal ulcer, or gastric adenocarcinoma. iceA was identified in bacterium samples obtained from all patients. Eleven (7.7%) of them were infected with multiple strains. Among the patients with nonmixed infection, iceA2 allele was detected in 118 (90.1%). iceA2 allele was associated with ulcer (P = 0.02) and with carcinoma (P = 0.001). iceA2 amplicons of 229, 334, or 549 bp were detected, but none of them was associated with the patient's disorder. iceA2 strains were more frequent in patients older than 7 years (P = 0.001). The gene was also more frequent in strains obtained from males (P = 0.02). cagA was more common in strains obtained from carcinoma (P = 0.0008) and ulcer patients (P < 0.006). cagA-positive strains were more frequent in children older than 7 years (P < 0.003). No association between cagA status and sex was found (P = 0.28). In conclusion, we think iceA should not be used as a reliable marker for predicting the clinical outcome of H. pylori infection.


Helicobacter pylori is a microaerophilic organism that is carried by more than half of all persons worldwide. It is now accepted as the most important cause of gastritis in human beings, as an essential factor in the etiopathogenesis of peptic ulcer disease (an important cause of morbidity), and as a risk factor for gastric cancer, a very common malignancy all over the world (42). The organism is one of the most genetically diverse bacteria, as demonstrated by DNA fingerprinting and other genotyping and DNA sequencing techniques (1, 36). There are also evidences of important geographic differences among H. pylori strains (15, 22, 39, 42). For example, from 50 to ca. 70% of the H. pylori strains obtained from patients from United States and Europe are cagA positive, a genotype that, at least in these places, appears to be related to the development of peptic ulcer disease and gastric adenocarcinoma (19). Otherwise, almost all strains isolated from East Asian patients are cagA positive, despite the disease status (14). Diverse geographic distribution of s alleles of vacA, which encodes a vacuolating cytotoxin, has also been observed. It has been reported that s1a variant is more common in American and Northern European strains, that s1b is more frequent in Latin American, Portuguese, and Spanish strains, and that s1c is almost exclusively found in patients from Eastern Asia (39). With regard to iceA, a gene induced by contact with gastric epithelial cells, little is known about its two distinct genotypes relationship to disease and, also, about their geographic distribution. It was reported that the iceA1 allele is related to the development of peptic ulcer disease in the United States (28) and The Netherlands (39), a result that has not been confirmed in other countries, such as Japan (15, 42), Korea (42), Colombia (42), and India (22). Recently, Peek et al. (27) detected higher acute inflammatory scores in the gastric mucosa of patients colonized with iceA1 strains, a result that could explain the association between this genotype and ulcer disease previously reported by Peek et al. (28) and van Doorn et al. (39).

Similar studies are still scanty in South American countries, where both peptic ulcer disease and gastric adenocarcinoma are very common, and we are not aware of any investigation, in Brazil, of iceA genotype distribution among H. pylori strains isolated from patients presenting with the different clinical situations associated with the bacterium. Furthermore, no such study has yet been performed on strains obtained from children. For these reasons, we undertook this study in order to investigate, in Brazilian children and adults, the distribution of iceA in H. pylori strains isolated from gastritis, duodenal ulcer, and gastric carcinoma patients. Studies on the diversity of H. pylori genes may be important not only for predicting the clinical outcomes of the infection but also to understand better the worldwide distribution of the microorganism and its evolutionary origins. Also, we aimed to investigate the frequency of infection by more than one H. pylori genotype, an aspect still little explored, especially in developing countries, where the high prevalence of the diseases associated with the bacterium could contribute to a high frequency of infection with multiple strains.

MATERIALS AND METHODS

This study was approved by the Ethics Committee of the Federal University of São Paulo (UNIFESP), Brazil. Consent to participate in the study was obtained from all patients; in the case of children, consent was also obtained from their parents or guardians.

Patients and gastric specimen collection.

A total of 142 patients, including 80 adults (32 female and 48 male; mean age, 52.4 years; median, 51.0 years; age range, 18 to 78 years) and 62 children (34 girls and 28 boys; mean age, 10.2 years; median, 10.5 years; age range, 3 to 17 years), most of them from the lower socioeconomic stratus, from the state of Minas Gerais in Brazil, were included in this study. All of them presented with gastric complaints and had culture proven H. pylori infection.

In the group of adult patients, 44 were endoscoped at the Dr. Celso Affonso de Oliveira Endoscopy Service or at the Gastrointestinal Endoscopy Service of the University Hospital–UFMG, when biopsy fragments from the gastric antrum and corpus were taken for microbiology and for histology. Among them, 24 (10 female and 14 male; mean age, 40.1 years; median, 39.0 years; age range, 18 to 61 years) had duodenal ulcer endoscopically proven, and 20 (10 female and 10 male; mean age, 55.1 years; median, 57.0 years; age range, 20 to 78 years) did not have gastric or duodenal lesions at endoscopy. After each procedure, endoscopes were cleansed with detergent, disinfected by immersion in 2.0% glutaraldehyde for 20 min, and then rinsed well in water.

The remaining 36 adult patients (12 female and 24 male; mean age, 59.1 years; median, 58.0 years; age range 32 to 77 years) were selected, if the diagnosis was histologically confirmed, among those who were scheduled for gastric surgery to remove distal gastric adenocarcinoma at the Surgical Clinic of University Hospital–UFMG, Luxemburgo Hospital, Santa Casa Hospital or Mário Penna Hospital of Oncology. Specimens of the stomach of these patients were also taken from the antrum and body regions, at least 2 cm away from the tumors, for microbiology. Fragments from the tumor were also removed for histology. All materials employed for sampling the stomach were cleansed in a way similar to that described for endoscopes, except that they were autoclaved when possible.

The 62 pediatric patients were submitted to upper endoscopy at the Pediatric Gastrointestinal Endoscopy Service of the University Hospital–UFMG. Among them, 23 (10 girls and 13 boys; mean age, 11.1 years; median, 12.0 years; age range, 3 to 17 years) had duodenal ulcer endoscopically proven and 39 (24 girls and 15 boys; mean age, 9.4 years; median, 10.0 years; age range, 3 to 15 years) did not have gastric or duodenal alterations at endoscopy. Endoscopy and biopsy collection were performed as described previously for adults.

All gastric fragments obtained for microbiology were immediately placed in a tube containing sodium thioglycolate broth (Difco, Detroit, Mich.), transported in an ice bath, and processed within 2 h. Fragments from the antral and body mucosa of the stomach and from the tumor were fixed in formalin for histological examination.

Histology.

Fragments fixed in formalin were dehydrated in an alcohol-xylene series and embedded in paraffin wax. Adjacent sections of 5 μm were obtained, placed on slides, stained with hematoxylin and eosin, and examined under a light microscope to confirm the presence of gastritis and gastric adenocarcinoma. All H. pylori-positive patients had some degree of gastritis ranging from mild to severe. The diagnosis of gastric adenocarcinoma was confirmed in all suspected cases.

H. pylori isolation.

Diagnosis of H. pylori infection was performed by culture as previously described (29, 30). Two kinds of H. pylori samples were obtained: a pool of colonies or isolated clones.

Pools of colonies were obtained from 90 patients, 49 children (18 with duodenal ulcer and 31 without ulcer) and 41 adults (21 with gastric carcinoma, 11 with duodenal ulcer, and 9 without ulcer or gastric carcinoma). H. pylori colonies grown onto Belo Horizonte medium were identified as described previously (31, 32) and were removed from the plates with a cotton swab and transferred to a microcentrifuge tube that contained 500 μl of sterile distilled water. After centrifugation at 6,000 × g for 5 min, the supernatant was discarded, and the pellets were maintained at −80°C for DNA extraction. Other portion of the growth was maintained at −80°C as previously described (29).

To obtain isolated clones, 5 to 25 colonies from each region of the stomach, presumptively identified as H. pylori by macroscopic morphology, were individually transferred to sheep blood agar plates which were incubated as described by Queiroz et al. (29). After 3 to 7 days of incubation, H. pylori was identified as described previously (31, 32). Part of the growth from each blood agar plate was removed and processed as described above for DNA isolation. The other part of the growth was maintained at −80°C (29). Isolated clones were obtained from 52 patients, 13 children (5 with duodenal ulcer and 8 without ulcer), and 39 adults (15 with gastric carcinoma, 13 with duodenal ulcer, and 11 without ulcer or gastric carcinoma). A total of 682 clones was obtained: 336 from the antrum (mean number, 9.3, from 1 to 25) and 346 from the corpus (mean number, 9.1, from 1 to 31).

The identification of H. pylori samples, both the pool of colonies and the isolated clones, was later confirmed by the presence of ureA, a gene that is present in all H. pylori strains (9), as described below.

DNA extraction.

All bacterial pellets were employed for DNA isolation by using a method previously described by Fox et al. (10). DNA was quantified by measuring the optical density at 260 nm and used for investigation of the presence of ureA, iceA alleles, and cagA.

ureA detection.

Genomic DNA from all samples was used for detection of ureA. Only samples which were ureA positive were employed in this study. Synthetic oligonucleotide primers and methodology reported by Clayton et al. (9) were used for the amplification of a 411-bp fragment of ureA, in an M. J. Research thermal cycler (M. J. Research, Watertown, Mass.). An Escherichia coli (human isolate) was used as negative control, H. pylori ATCC 49503 was used as positive control, and distilled water was used as internal-reaction negative control.

iceA identification.

PCR amplification was performed by using the synthetic oligonucleotide primers and the methodology described by van Doorn et al. (39), though slightly modified. According to these authors, positive iceA1 reaction generates a fragment of 247 bp and the iceA2 allele can be detected as 124-, 229-, or 334-bp fragments, depending on the number of 105-bp repeated insertions.

In summary, allele-specific PCR assays were used to detect iceA1 and iceA2 (39). For each sample the PCR mixture (20 μl, final volume) contained approximately 50 ng of genomic DNA, 25 pmol of each primer, each deoxyribonucleoside triphosphate (Life Technologies) at a concentration of 200 μM, and 1 U of Taq DNA polymerase. The reaction mixtures were cycled in an automated M. J. Research thermal cycler under the following conditions: 9 min of preincubation at 94°C followed by a touchdown program which consisted of 30 s at 95°C; 45 s at the annealing temperature, which started at 65°C and decreased 1°C each two cycles up to 50°C, at which temperature 10 cycles were carried out; and 45 s at 72°C. The final cycle was an extension step at 72°C for 5 min. H. pylori ATCC 49503 was used as a positive control for iceA1, H. pylori ATCC 43504 was used as positive control for the iceA2 allele (334-bp amplicon), an Escherichia coli (human isolate) was used as a negative control for both reactions, and distilled water was used as the internal-reaction negative control.

cagA detection.

PCR amplification of cagA was performed with synthetic oligonucleotide primers and by using the methodology reported by Peek et al. (26). H. pylori Tx30A was used as a negative control, H. pylori ATCC 49503 was employed as a positive control, and distilled water was used as an internal-reaction negative control. Positive reactions yielded a 349-bp final product.

PCR product detection.

ureA, iceA, and cagA amplimers were resolved in 5% polyacrylamide gels stained with silver nitrate as described by Bassam et al. (4) and modified by Rocha (33). Standards of 50 and 100 bp (Life Technologies) were employed as molecular size markers.

Statistical analysis.

Data were analyzed statistically by the two-tailed χ2 test with Yates' correction or by Fisher's exact test. The significance level was set at P value of <0.05.

RESULTS

Among the 142 patients studied, 59 had gastritis only, 47 had duodenal ulcer, and 36 had gastric adenocarcinoma.

The distribution of cagA status among children and adults is shown in Table 1. The gene was more frequently found in strains obtained from duodenal ulcer (P < 0.006) and gastric carcinoma (P < 0.0008) patients.

TABLE 1.

cagA status of H. pylori strains isolated from children and adults with gastritis only, duodenal ulcer, and gastric carcinoma

cagA group No. of strains (%) isolated from:
Children with:
Adults with:
Ulcer Gastritis Ulcer Gastritis Carcinoma
Positive 18 (78.3) 22 (56.4) 21 (87.5) 11 (55.0) 34 (94.4)
Negative 5 (21.7) 17 (43.6) 3 (12.5) 9 (45.0) 2 (5.6)
Total 23 39 24 20 36

It was also more frequent in H. pylori strains isolated from patients older than 7 years (P = 0.003). However, when ulcer patients were considered separately, no statistical difference was observed in the distribution of the gene according to age (younger [0 of 1] and older [39 of 46] than 7 years) (P = 0.2). Also, no difference was found in cagA status between males and females (P = 0.28), both in children (P = 0.07) and in adults (P = 0.51).

No mixed infection with cagA-positive and cagA-negative strains was detected among the 52 patients from whom we obtained H. pylori isolated clones.

iceA was identified in bacterium samples obtained from all the patients we studied (Table 2). Among them, 131 (92.3%) patients were colonized with bacterium harboring a single iceA genotype (nonmixed infection). The other 11 (7.7%) patients, who were infected with H. pylori strains showing more than one iceA genotype (mixed infection) (Table 2), were not included in the analysis of the relationship between gastric disorders and specific iceA genotypes.

TABLE 2.

Distribution of iceA genotypes in H. pylori strains isolated from children and adults with gastritis, duodenal ulcer, and gastric carcinoma

Genotype No. of strains isolated from:
Total no. of strains
Children with:
Adults with:
Gastritis Ulcer Gastritis Ulcer Cancer
Single-strain infection 38 20 17 23 33 131
iceA1 8 3 1 1 13
iceA2 30 20 14 22 32 118
  229 bp 15 9 10 15 16 65
  334 bp 14 11 4 7 16 52
  549 bp 1 1
Multiple-strain infection 1 3 3 1 3 11
iceA1 plus iceA2 (229 bp) 1 1 2
iceA1 plus iceA2 (334 bp) 1 1
iceA1 plus iceA2 (229 plus   334 bp) 2 2
iceA2 (229 plus 334 bp) 1 3 1 1 6
Total 39 23 20 24 36 142

Among patients with a nonmixed infection, iceA1 was detected in H. pylori samples isolated from 13 (9.9%): 11 of 55 (20.0%) with gastritis, 1 of 43 (2.3%) with duodenal ulcer, and 1 of 33 (3.0%) with gastric adenocarcinoma (Table 2).

The iceA2 allele was detected in samples obtained from 118 (90.1%) patients with nonmixed infection: 44 of 55 (80.0%) with gastritis, 42 of 43 (97.7%) with duodenal ulcer, and 32 of 33 (97.0%) with gastric adenocarcinoma (Table 2). A significant association between iceA2 and duodenal ulcer was observed when children and adults were considered together (P < 0.02) and when the children's group was analyzed separately (P = 0.04). An association between iceA2 allele and gastric carcinoma was found (P = 0.03) when all patients with gastritis were considered in the analysis. The distribution of iceA genotypes was similar in children and adults, whether carcinoma patients were included (P = 0.30) or not (P = 0.75) (Table 2).

When all patients with nonmixed infection were considered together, iceA2 was more frequently observed in patients older than 7 years (P = 0.001). The allele was also more frequently found in H. pylori strains obtained from patients older than 7 years when gastritis only patients were considered (P = 0.0009) and when duodenal ulcer patients were analyzed separately (P = 0.02). Considering the whole group of patients with nonmixed infection, an iceA2 genotype was more frequently found in males (P = 0.02).

All iceA2 isolates could be divided in three types according to PCR product size: 229, 334, or 549 bp (Table 2). No association was observed between the size of iceA2 amplicon and the patient's disorder, both in adults and children.

Eleven patients (7.7%) were colonized with H. pylori strains harboring different iceA genotypes (mixed infection). Interestingly, one patient was colonized with a strain presenting an iceA2 amplified product of 229 bp in the antrum and with other strain showing a PCR product of 334 bp in the gastric body. No difference in the distribution of mixed infection was observed when adults (7 of 11 [63.6%]) were compared to children (4 of 11 [36.4%]) (P = 0.76) (Table 2). Also, a statistical difference in the distribution of single and mixed infection was not observed when patients with gastritis were compared to those with duodenal ulcer (P = 1.00) or with gastric carcinoma (P = 0.71). A mixed infection was more frequently seen in males (P = 0.03).

An association between iceA2 and cagA was observed when all patients with a nonmixed infection were considered together (P = 0.0009).

DISCUSSION

H. pylori infection is now recognized as an important risk factor for peptic ulcer disease, gastric adenocarcinoma, and mucosa-associated lymphoid tissue (MALT) lymphoma (12, 13, 25, 34). Despite being one of the most common bacterial infections all over the world, most infected individuals are asymptomatic throughout their lives; only a minority of them develop such severe diseases. Although host and environmental factors could be important, such a discrepancy may be related to the great genetic diversity of the species. In fact, infection with certain H. pylori genotypes, among them cagA-positive and vacA s1 variants, seems to be associated with progression to more severe diseases, such as peptic ulceration and gastric carcinoma (3, 5, 6, 17, 18, 20, 39), at least in Western countries.

A novel gene, designated iceA (from “inducible by contact with epithelium” of the gastric mucosa), has recently been reported by Peek et al. (28). It was demonstrated that one of its alleles, iceA1, is significantly associated with peptic ulcer disease in the United States (28) and Holland (39). According to Peek et al. (27), iceA1 expression is associated with a higher activity of the gastric inflammation that is present in virtually all H. pylori-infected individuals, a condition that increases the risk for developing ulcer disease and gastric carcinoma. However, as demonstrated previously for cagA and vacA variants (14, 24, 40) in East Asian populations, iceA1 genotype was not found to be correlated with the presence of peptic ulceration in Japan (15, 42), Korea, Colombia, the United States (Texas) (42), and India (22).

The present study describes, for the first time, an analysis of iceA genotypes in H. pylori strains isolated from children and adults from Brazil. The number of reports on this subject is scanty, and the results on the association of the gene with specific gastrointestinal disorders are still inconclusive. Also, this study confirms several findings reported for cagA in Western countries, such as the correlation between the presence of the gene and peptic ulceration and gastric adenocarcinoma.

All of our strains could have iceA typed by a method similar to that reported by van Doorn et al. (39).

In contrast to the results reported for H. pylori strains isolated from Dutch (39), Japanese (15, 42), and Korean (42) patients, iceA2 was found to be the most frequent genotype detected in our population (90.1% among patients with a nonmixed infection).

In regard to the association of iceA alleles with gastroduodenal diseases, our results are distinct from those reported by Peek et al. (28) and van Doorn et al. (39), who found a significant association between the iceA1 allele and peptic ulceration in American and Dutch patients, respectively. We found that the iceA2 genotype was most frequently found in H. pylori strains isolated from patients with duodenal ulcer and with gastric carcinoma. Similar results have been recently reported by Yamaoka et al. (42) for strains obtained from patients from Colombia and from Texas and by Mukhopadhyay et al. (22) for Indian strains. If the activity of the inflammatory response, which increases the risk for peptic ulcer disease and gastric carcinoma, is higher in the gastric mucosa of patients infected with strains that express iceA1 (27), and if most peptic ulcer and gastric carcinoma patients in Brazil and in the countries cited above harbors iceA2 H. pylori strains, it is probable that host and/or other bacterial factors could be more important than iceA1 transcription in vivo. Are iceA and other gene expressions coregulated? We could hypothesize that iceA genotypes are not reliable markers of peptic ulcer disease and gastric carcinoma and that the association observed, in some places with iceA1 and in others with iceA2, could be related to other noncontrolled experimental variables. In fact, it is difficult to admit that iceA2, a gene that is considered as a protective factor in some regions and that is associated with more severe diseases in other places, could be considered a molecular marker of more virulent H. pylori strains. Further studies, including the investigation of H. pylori iceA distribution and expression in different populations, are needed to help us understand better the association between the gene and the disease.

Similarly to the vacA s1 variants, maybe iceA genotyping could be used as a marker of H. pylori strain geographic distribution and evolutionary origin. We should also consider that host-determined factors, such as the expression of specific receptors or antagonist factors, are certainly involved in the whole process and, consequently, could be determinant of the global distribution of organism strains and eventually of the clinical outcome of the infection. Probably, factors that explain why s1c variant of vacA is almost exclusively found in Asian patients, and why s1a and s1b variants are found in people living in the same region (38) and, sometimes, in the same individual (11) could help us understand why iceA2 is the most prevalent genotype in some regions and why iceA1 was not found to be related to more severe H. pylori-associated diseases in Brazil and in other countries.

The distribution of iceA2 229- and 334-bp amplicons was almost the same in the strains we studied. Only one sample yielded an amplicon of aproximately 540 bp, a nondescribed one, probably containing four 105-bp in-frame duplications.

Both cagA positivity and the iceA2 genotype were more frequently found in patients older than 7 years. Correlation of the frequency of some vacA alleles and cagA positivity with age was recently reported by Alarcon et al. (2), Gusmão et al. (11), and Queiroz et al. (29). The finding that colonization with iceA2 strains is age correlated, being more common in older patients, has never been reported before. It could be related to age-dependent expression of host factors such as observed by Çelik et al. (8) for Leb receptors.

iceA2 was more frequently found in males. This finding was only observed when all patients with a nonmixed infection were considered, but not when gastritis only, duodenal ulcer, and gastric carcinoma patients were analyzed separately. It is probably related to the higher number of males in the gastric carcinoma group (69.7%) and not to, for example, hormonal differences between sexes.

Infections with multiple H. pylori strains have been reported by many authors (16, 21, 23, 35, 38). Mixed infection was detected in 7.7% patients and was not related to age and disease. The frequency we found is lower than that reported by van Doorn et al. (39) for Dutch patients (14.9%). Taking into account that the higher the prevalence of the infection the higher the risk of becoming infected with different strains, we should expect a higher prevalence of multiple infection in our patients, since the prevalence of H. pylori infection in some Brazilian regions reaches rates of 80% in symptomatic and asymptomatic children older than 12 years of age (7). However, if we consider that iceA2 is observed in more than 90% of our patients, the risk of becoming infected with both iceA1 and iceA2 is low. Furthermore, the prevalence of mixed infection that we observed could be underestimated because of the low number of possible combinations between iceA1 genotype and iceA2 amplicons.

We found a significant association between cagA positivity and the iceA2 allele. In contrast, van Doorn et al. (39) did not find any association between these genotypes. Our result probably reflects the high prevalence of both cagA and the iceA2 allele in H. pylori strains isolated from our population.

In conclusion, we were not able to confirm the reports of van Doorn et al. (39) and Peek et al. (27, 28), who found the iceA1 genotype to be associated with peptic ulcer disease. We think that the statistical association we found between the iceA2 genotype and the different H. pylori-associated disorders could reflect the high prevalence of this genotype in H. pylori strains in the population we studied. We think that the gene should not be used as a reliable marker, at least in a Brazilian setting, for predicting the clinical outcome of H. pylori infection. Interpretation of this kind of association should be cautious and must consider genotypic and phenotypic organism characteristics and related disease associations in different geographic regions and ethnic groups.

ACKNOWLEDGMENTS

This work was supported by grants from CNPq and FAPEMIG–Brazil. A.A.R.A. is taking his doctoral degree at the Department of Microbiology, Immunology and Parasitology, School of Medicine, Federal University of São Paulo, and V.R.D.G. is taking a master's degree at the Department of Microbiology, Institute of Biology, Federal University of Minas Gerais; they were supported by CAPES–Brazil scholarships. G.B.C. is a medical student and was partly supported by a CNPq–Brazil scholarship.

We acknowledge the generosity of E. Kalapothakis for providing the Taq DNA polymerase employed in this study.

REFERENCES

  • 1.Akopyanz N, Bukanov N O, Westblom T U, Kresovich S, Berg D E. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res. 1992;20:5137–5142. doi: 10.1093/nar/20.19.5137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Alarcón T, Domingo D, Martinez M J, López-Brea M. cagA gene and vacA alleles in Spanish Helicobacter pylori clinical isolates from patients of different ages. FEMS Immunol Med Microbiol. 1999;24:215–219. doi: 10.1111/j.1574-695X.1999.tb01285.x. [DOI] [PubMed] [Google Scholar]
  • 3.Atherton J C, Peek R M, Tham K T, Cover T L, Blaser M J. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology. 1997;112:92–99. doi: 10.1016/s0016-5085(97)70223-3. [DOI] [PubMed] [Google Scholar]
  • 4.Bassam B J, Caetano-Anlollés G, Gresshoff P M. Fast and sensitive silver staining of DNA in polyacrilamide gels. Anal Biochem. 1991;196:80–83. doi: 10.1016/0003-2697(91)90120-i. [DOI] [PubMed] [Google Scholar]
  • 5.Blaser M J, Perez-Perez G L, Kleanthous H, Cover T L, Peek R M, Stemmermann G N, Chyou P H, Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of stomach. Cancer Res. 1995;55:2111–2115. [PubMed] [Google Scholar]
  • 6.Blaser M J, Chyou P H, Nomura A. Age at stablishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res. 1995;55:562–565. [PubMed] [Google Scholar]
  • 7.Carvalho A S T, Queiroz D M M, Mendes E N, Rocha G A, Penna F J. Diagnosis and distribution of Helicobacter pylori in the gastric mucosa of symptomatic children. Braz J Med Biol Res. 1991;24:163–166. [PubMed] [Google Scholar]
  • 8.Çelik J, Su B, Tirén Y, Yigael F, Thoresson A C, Engstrand L, Sandstedt B, Bernander S, Normark S. Virulence and colonization-associated properties of Helicobacter pylori isolated from children and adolescents. J Infect Dis. 1998;177:247–252. doi: 10.1086/517365. [DOI] [PubMed] [Google Scholar]
  • 9.Clayton C L, Kleanthous H, Coates P J, Morgan D D, Tabaqchali S. Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol. 1992;30:192–200. doi: 10.1128/jcm.30.1.192-200.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Fox J G, Dewhirst F E, Fraser G J, Paster B J, Shames B, Murphy J C. Intracellular Campylobacter-like organism from ferrets and hamsters with proliferative bowel disease is a Desulfovibrio sp. J Clin Microbiol. 1994;32:1229–1237. doi: 10.1128/jcm.32.5.1229-1237.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Gusmão V R, Mendes E N, Queiroz D M M, Rocha G A, Rocha A M C, Ashour A A R, Carvalho A S T. vacA genotypes in Helicobacter pylori strains isolated from children without duodenal ukcer in Brasil. J Clin Microbiol. 2000;38:2853–2857. doi: 10.1128/jcm.38.8.2853-2857.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hentschel I, Brandstatter G, Dragosics B, Hirschl A M, Nemec H, Schutze K, Taufer M, Wurzer H. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med. 1993;328:308–312. doi: 10.1056/NEJM199302043280503. [DOI] [PubMed] [Google Scholar]
  • 13.International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC/WHO. 1994;61:177–241. [Google Scholar]
  • 14.Ito Y, Azuma T, Ito S, Miyaji H, Hirai M, Yamazaki Y, Sato F, Kato T, Kohli Y, Kuriyama M. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol. 1997;35:1710–1714. doi: 10.1128/jcm.35.7.1710-1714.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ito Y, Azuma T, Ito S. Sequence analysis and clinical significance of the iceA gene from Helicobacter pylori strains in Japan. J Clin Microbiol. 2000;38:483–488. doi: 10.1128/jcm.38.2.483-488.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Jorgensen M, Daskalopoulos G, Waburton V, Mitchell H M, Hazell S I. Multiple strain colonization and metronidazole resistance in Helicobacter pylori-infected patients: identification from sequential and multiple biopsy specimens. J Infect Dis. 1996;174:631–635. doi: 10.1093/infdis/174.3.631. [DOI] [PubMed] [Google Scholar]
  • 17.Kuipers E J, Thijs J C, Festen H P M. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther. 1995;9(Suppl. 2):59–69. [PubMed] [Google Scholar]
  • 18.Labigne A, Reuse H. Determinants of Helicobacter pylori pathogenicity. Infect Agents Dis. 1996;5:191–202. [PubMed] [Google Scholar]
  • 19.Miehlke S, Kibler K, Kim J G, Figura N, Small S M, Graham D Y, Go M F. Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol. 1996;17:1322–1325. [PubMed] [Google Scholar]
  • 20.Mobley H L. Defining Helicobacter pylori as a pathogen: strain heterogeneity and virulence. Am J Med. 1997;100:2–11. doi: 10.1016/s0002-9343(96)80223-3. [DOI] [PubMed] [Google Scholar]
  • 21.Morales-Espinosa R, Castillo-Rojas G, Gonzalez-Valencia G, Ponce de León S, Cravioto A, Atherton J C, López-Vidal Y. Colonization of Mexican patients by multiple Helicobacter pylori strains with different vacA and cagA genotypes. J Clin Microbiol. 1999;9:3001–3004. doi: 10.1128/jcm.37.9.3001-3004.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Mukhopadhyay A K, Kersulyte D, Jeong J N, Datta S, Ito Y, Chowdhury A, Chowdhury S, Santra A, Bhattachary S K, Azuma T, Nair G B, Berg D E. Distinctivness of genotypes of Helicobacter pylori in Calcutta, India. J Bacteriol. 2000;182:3219–3227. doi: 10.1128/jb.182.11.3219-3227.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA. 1994;272:65–69. [PubMed] [Google Scholar]
  • 24.Pan Z J, Berg D E, van der Hulst R W M, Su W W, Raudonikiene A, Xiao S S, Dankert J, Tytgat G N J, van der Ende A. Prevalence of vacuolating cytotoxin production and distribution of distinct vacA alleles in Helicobacter pylori from China. J Infect Dis. 1998;178:220–226. doi: 10.1086/515601. [DOI] [PubMed] [Google Scholar]
  • 25.Parsonnet J, Friedman G D, Vandersteen D P, Chang Y, Vogelman J H, Orentreich N, Sibley R K. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127–1131. doi: 10.1056/NEJM199110173251603. [DOI] [PubMed] [Google Scholar]
  • 26.Peek R M, Miller G G, Tham K T, Perez-Perez G I, Zhao X, Atherton J C, Blaser M J. Heightened inflammatory response and cytokine expression in vivo to cagA+Helicobacter pylori. Lab Investig. 1995;71:760–770. [PubMed] [Google Scholar]
  • 27.Peek R M, van Doorn L-J, Donahue J P, Tham K T, Figueiredo C, Blaser M J, Miller G. Quantitative detection of Helicobacter pylori gene expression in vivo and relationship to gastric pathology. Infect Immun. 2000;68:5488–5495. doi: 10.1128/iai.68.10.5488-5495.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Peek R M, Thompson S A, Donahue J P, Tham K T, Atherton J C, Blaser M J, Miller G G. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA that is associated with clinical outcome. Proc Assoc Am Physicians. 1998;110:531–544. [PubMed] [Google Scholar]
  • 29.Queiroz D M M, Mendes E N, Carvalho A S T, Rocha G A, Rocha A M C, Soares T F, Santos A, Cabral M M D A, Nogueira A M M F. Factors associated with Helicobacter pylori infection by a cagA-positive strain in children. J Infect Dis. 2000;181:626–630. doi: 10.1086/315262. [DOI] [PubMed] [Google Scholar]
  • 30.Queiroz D M M, Mendes E N, Rocha G A. Indicator medium for isolation of Campylobacter pylori. J Clin Microbiol. 1987;25:2378–2379. doi: 10.1128/jcm.25.12.2378-2379.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Queiroz D M M, Mendes E N, Rocha G A, Moura S B, Resende L M H, Barbosa A J A, Coelho L G V, Passos M C F, Castro L P, Oliveira C A, Lima G F., Jr Effect of Helicobacter pylori eradication on antral gastrin-and somatostatin-immunoreactive cell density and gastrin and somatostatin concentrations. Scand J Gastroenterol. 1993;28:858–864. doi: 10.3109/00365529309103125. [DOI] [PubMed] [Google Scholar]
  • 32.Rocha G A, Queiroz D M M, Mendes E N, Lage A P, Barbosa A J A. Simple carbolfuchsin staining for showing C. pylori and other bacteria in gastric mucosa. J Clin Pathol. 1989;42:1004–1005. doi: 10.1136/jcp.42.9.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Rocha J L F. O receptor V2 de vasopressina e o canal de água aquaporina-2 no diabetes insipidus nefrogênico. Master's thesis. Belo Horizonte, Brazil: Instituto de Ciências Biológicas de UFMG; 1995. [Google Scholar]
  • 34.Sung J Y, Chung S C S, Ling T K W, Yang M Y, Leunk V K S, Ng E K W, Li M K K, Cheng A F B, Li A K C. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med. 1995;332:139–142. doi: 10.1056/NEJM199501193320302. [DOI] [PubMed] [Google Scholar]
  • 35.Taylor N S, Fox J G, Akopyants N S, Berg D E, Thompson N, Shames B, Yan L, Fontham E, Janney F, Hunter F M, Correa P. Long-term colonization with single and multiple strains of Helicobacter pylori asssessed by DNA fingerprinting. J Clin Microbiol. 1995;33:918–923. doi: 10.1128/jcm.33.4.918-923.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Tee W, Lambert J, Smallwood R, Schembri M, Ross B C, Dwyer B. Ribotyping of Helicobacter pylori from clinical specimens. J Clin Microbiol. 1992;30:1562–1567. doi: 10.1128/jcm.30.6.1562-1567.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Tummuru M K R, Cover T L, Blaser M J. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun. 1993;61:1799–1809. doi: 10.1128/iai.61.5.1799-1809.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.van Doorn L-J, Figueiredo C, Megráud F, Pena S, Midolo P, Queiroz D M M, Carneiro F, Vanderborght B, Pegado M G F, Sanna R, de Boer W, Schneeberger P M, Correa P, Ng E K W, Atherton J, Blaser M J, Quint W G V. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology. 1999;116:823–839. doi: 10.1016/s0016-5085(99)70065-x. [DOI] [PubMed] [Google Scholar]
  • 39.van Doorn L-J, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, de Boer W, Quint W. Clinical relevance of cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology. 1998;115:58–66. doi: 10.1016/s0016-5085(98)70365-8. [DOI] [PubMed] [Google Scholar]
  • 40.Wang H J, Kuo J T, Yeh A A M, Chang P C I, Wang W C. Vacuolating toxin production in clinical isolates of Helicobacter pylori with different vacA genotypes. J Infect Dis. 1998;178:207–212. doi: 10.1086/515600. [DOI] [PubMed] [Google Scholar]
  • 41.Westblom T U, Czinn S J, Nedrud J G. Gastroduodenal disease and Helicobacter pylori: pathophysiology, diagnosis and treatment. Curr Top Microbiol Immunol. 1999;241:301–313. [Google Scholar]
  • 42.Yamaoka Y, Kodama T, Gutierrez O, Kim J G, Kashima K, Graham D Y. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol. 1999;37:2274–2279. doi: 10.1128/jcm.37.7.2274-2279.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES